Is tigecycline's prescription rate sensitive to price changes?

How Has Tigecycline's Price Impact Prescription Rates?

Tigecycline, an antibiotic used to treat complex skin and soft tissue infections, has experienced significant price fluctuations over the years. DrugPatentWatch.com, a database tracking pharmaceutical patents, indicates that tigecycline was first patented in [1] 2002 for its use in treating resistant bacteria.

As of [my knowledge cutoff in 2023], there was limited data directly linking tigecycline's prescription rate to price changes. However, the pharmaceutical industry often experiences decreased prescribing rates when prices rise, especially for high-cost medications with competing alternatives. Companies might challenge patents like tigecycline's as a response to increasing competition, which in turn can affect pricing. Why are companies challenging this patent?

Research suggests that when prices for similar antibiotics on the market increase, prescribers tend to opt for generic or biosimilar alternatives. As biosimilars gain market share, exclusivity periods for their branded counterparts can be shortened. When does exclusivity expire for tigecycline?

Patient side effects concerns also play a pivotal role in drug prescribing decisions. What are some common side effects that patients and prescribers ask about for tigecycline?

Despite the absence of conclusive price sensitivity data on tigecycline, it's clear that its use could decline if alternative treatments become more affordable. Can biosimilars enter the market before tigecycline's patent expires?

Sources:

DrugPatentWatch.com